User: Guest  Login
If you experience problems opening the document, please try this link.
Title:

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

Document type:
Zeitschriftenaufsatz
Author(s):
Fietz, Simon; Zarbl, Romina; Niebel, Dennis; Posch, Christian; Brossart, Peter; Gielen, Gerrit H.; Strieth, Sebastian; Pietsch, Torsten; Kristiansen, Glen; Bootz, Friedrich; Landsberg, Jennifer; Dietrich, Dimo
Journal title:
Cancer Immunology, Immunotherapy
Year:
2020
Journal volume:
70
Journal issue:
6
Pages contribution:
1781-1788
Fulltext / DOI:
doi:10.1007/s00262-020-02777-4
Publisher:
Springer Science and Business Media LLC
E-ISSN:
0340-70041432-0851
Date of publication:
16.11.2020
 BibTeX